These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 11896268)
1. Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis. Dye C; Williams BG; Espinal MA; Raviglione MC Science; 2002 Mar; 295(5562):2042-6. PubMed ID: 11896268 [TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
3. HIV infection and multidrug-resistant tuberculosis: the perfect storm. Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830 [TBL] [Abstract][Full Text] [Related]
4. Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs. Zumla A; Abubakar I; Raviglione M; Hoelscher M; Ditiu L; McHugh TD; Squire SB; Cox H; Ford N; McNerney R; Marais B; Grobusch M; Lawn SD; Migliori GB; Mwaba P; O'Grady J; Pletschette M; Ramsay A; Chakaya J; Schito M; Swaminathan S; Memish Z; Maeurer M; Atun R J Infect Dis; 2012 May; 205 Suppl 2():S228-40. PubMed ID: 22476720 [TBL] [Abstract][Full Text] [Related]
5. [Mycobacterium tuberculosis with extensive resistance]. Labie D Med Sci (Paris); 2007 Feb; 23(2):205-9. PubMed ID: 17291432 [No Abstract] [Full Text] [Related]
6. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000]. Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091 [TBL] [Abstract][Full Text] [Related]
7. High frequency of multidrug-resistant Mycobacterium tuberculosis isolates in Georgetown, Guyana. Menner N; Günther I; Orawa H; Roth A; Rambajan I; Wagner J; Hahn H; Persaud S; Ignatius R Trop Med Int Health; 2005 Dec; 10(12):1215-8. PubMed ID: 16359400 [TBL] [Abstract][Full Text] [Related]
8. AIDS and tuberculosis - a lethal combination. Ojcius D Nat Rev Microbiol; 2004 Nov; 2(11):858. PubMed ID: 15523763 [No Abstract] [Full Text] [Related]
9. Drug-resistant tuberculosis in Cuba. Results of the three global projects. Montoro E; Lemus D; Echemendía M; Armas L; González-Ochoa E; Llanes MJ; Valdivia JA Tuberculosis (Edinb); 2006; 86(3-4):319-23. PubMed ID: 16569512 [TBL] [Abstract][Full Text] [Related]
10. Management of multi-drug resistant tuberculosis: practitioner's view point. Prasad R Indian J Tuberc; 2007 Jan; 54(1):3-11. PubMed ID: 17455417 [TBL] [Abstract][Full Text] [Related]
11. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework. Pablos-Mendez A; Gowda DK; Frieden TR Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008 [TBL] [Abstract][Full Text] [Related]
12. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407 [TBL] [Abstract][Full Text] [Related]
13. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus. Kam KM; Yip CW Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147 [TBL] [Abstract][Full Text] [Related]
14. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance. Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897 [TBL] [Abstract][Full Text] [Related]
15. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda. Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021 [TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154 [TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of Estonian patients with primary multidrug-resistant versus drug-susceptible tuberculosis. Lockman S; Kruuner A; Binkin N; Levina K; Wang Y; Danilovitsh M; Hoffner S; Tappero J Clin Infect Dis; 2001 Feb; 32(3):373-80. PubMed ID: 11170944 [TBL] [Abstract][Full Text] [Related]